Follow
Adrian Soto-Mota, MD, PhD, FACP.
Adrian Soto-Mota, MD, PhD, FACP.
National Institute of Medical Sciences and Nutrition Salvador Zubiran
Verified email at incmnsz.mx
Title
Cited by
Cited by
Year
Safety and tolerability of sustained exogenous ketosis using ketone monoester drinks for 28 days in healthy adults
A Soto-Mota, H Vansant, RD Evans, K Clarke
Regulatory Toxicology and Pharmacology 109, 104506, 2019
852019
Why a d-β-hydroxybutyrate monoester?
A Soto-Mota, NG Norwitz, K Clarke
Biochemical Society Transactions 48 (1), 51-59, 2020
652020
Multi-loop model of Alzheimer disease: an integrated perspective on the Wnt/GSK3β, α-synuclein, and type 3 diabetes hypotheses
NG Norwitz, AS Mota, SG Norwitz, K Clarke
Frontiers in Aging Neuroscience 11, 184, 2019
372019
Elevated LDL cholesterol with a carbohydrate-restricted diet: evidence for a “lean mass hyper-responder” phenotype
NG Norwitz, D Feldman, A Soto-Mota, T Kalayjian, DS Ludwig
Current Developments in Nutrition 6 (1), nzab144, 2022
352022
The low‐harm score for predicting mortality in patients diagnosed with COVID‐19: a multicentric validation study
A Soto‐Mota, BA Marfil‐Garza, E Martínez Rodríguez, ...
Journal of the American College of Emergency Physicians Open 1 (6), 1436-1443, 2020
292020
Stroke in systemic lupus erythematosus: epidemiology, mechanism, and long-term outcome
P Guraieb-Chahín, C Cantú-Brito, A Soto-Mota, L Guerrero-Torres, ...
Lupus 29 (5), 437-445, 2020
282020
LRP5, bone density, and mechanical stress: a case report and literature review
NG Norwitz, AS Mota, M Misra, KE Ackerman
Frontiers in endocrinology 10, 452741, 2019
262019
Exogenous ketosis in patients with type 2 diabetes: Safety, tolerability and effect on glycaemic control
A Soto‐Mota, NG Norwitz, R Evans, K Clarke, TM Barber
Endocrinology, Diabetes & Metabolism 4 (3), e00264, 2021
252021
Exogenous d‐β‐hydroxybutyrate lowers blood glucose in part by decreasing the availability of L‐alanine for gluconeogenesis
A Soto‐Mota, NG Norwitz, RD Evans, K Clarke
Endocrinology, Diabetes & Metabolism 5 (1), e00300, 2022
192022
Ketotherapeutics for neurodegenerative diseases
NG Norwitz, JG Jaramillo, K Clarke, A Soto
International review of neurobiology 155, 141-168, 2020
182020
Ketones: potential to achieve brain energy rescue and sustain cognitive health during ageing
É Myette-Côté, A Soto-Mota, SC Cunnane
British Journal of Nutrition 128 (3), 407-423, 2022
172022
The lipid energy model: reimagining lipoprotein function in the context of carbohydrate-restricted diets
NG Norwitz, A Soto-Mota, B Kaplan, DS Ludwig, M Budoff, A Kontush, ...
Metabolites 12 (5), 460, 2022
172022
Prospective predictive performance comparison between clinical gestalt and validated COVID-19 mortality scores
A Soto-Mota, BA Marfil-Garza, S Castiello-de Obeso, ...
Journal of Investigative Medicine 70 (2), 415-420, 2022
172022
Restricting carbohydrates and calories in the treatment of type 2 diabetes: a systematic review of the effectiveness of ‘low-carbohydrate’interventions with differing energy levels
AP Nicholas, A Soto-Mota, H Lambert, AL Collins
Journal of nutritional science 10, e76, 2021
142021
Impact of healthcare strain on access to mechanical ventilation and mortality of hospitalized COVID-19 patients: a retrospective cohort study
I Núñez, A Soto-Mota
Transactions of The Royal Society of Tropical Medicine and Hygiene 117 (5 …, 2023
122023
The effects of endogenously‐and exogenously‐induced hyperketonemia on exercise performance and adaptation
DJ Dearlove, A Soto Mota, D Hauton, K Pinnick, R Evans, J Miller, ...
Physiological Reports 10 (10), e15309, 2022
82022
COVID-19 pandemic and the consequential effect on patients with endometriosis
MS Ashkenazi, OL Huseby, G Kroken, A Soto-Mota, M Pents, A Loschiavo, ...
Human Reproduction Open 2022 (2), hoac013, 2022
82022
Evidence for the carbohydrate–insulin model in a reanalysis of the Diet Intervention Examining The Factors Interacting with Treatment Success (DIETFITS) trial
A Soto-Mota, MA Pereira, CB Ebbeling, L Aronica, DS Ludwig
The American Journal of Clinical Nutrition 117 (3), 599-606, 2023
72023
Elevated LDL-cholesterol levels among lean mass hyper-responders on low-carbohydrate ketogenic diets deserve urgent clinical attention and further research
NG Norwitz, MR Mindrum, P Giral, A Kontush, A Soto-Mota, TR Wood, ...
Journal of Clinical Lipidology 16 (6), 765-768, 2022
72022
Case report: Hypercholesterolemia “Lean Mass Hyper-Responder” phenotype presents in the context of a low saturated fat carbohydrate-restricted diet
NG Norwitz, A Soto-Mota, D Feldman, S Parpos, M Budoff
Frontiers in Endocrinology 13, 830325, 2022
62022
The system can't perform the operation now. Try again later.
Articles 1–20